Multispectral imaging for quantitative and compartment-specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients-Reference-Cited by-同舟云学术

Multispectral imaging for quantitative and compartment-specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients

Published:2018-02-05 Issue:4 Volume:244 Page:421-431
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol

Author:

Mezheyeuski Artur¹^ORCID,Bergsland Christian Holst²,Backman Max¹,Djureinovic Dijana¹,Sjöblom Tobias¹,Bruun Jarle²,Micke Patrick¹

Affiliation:

1. Department of Immunology, Genetics and Pathology; Uppsala University; Uppsala Sweden

2. Department of Molecular Oncology, Institute for Cancer Research, the Norwegian Radium Hospital; Oslo University Hospital; Oslo Norway

Funder

Swedish Cancer Society (Cancerfonden Lions Cancerfonden)

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference60 articles.

1. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma;Larkin;N Engl J Med,2015

2. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial;Rosenberg;Lancet,2016

3. Pembrolizumab for platinum- and cetuximab-refractory head and neck cancer: results from a single-arm, phase II study;Bauml;J Clin Oncol,2017

4. Harnessing the immune system to provide long-term survival in patients with melanoma and other solid tumors;Eggermont;Oncoimmunology,2014

5. PD-1 blockade in tumors with mismatch-repair deficiency;Le DT;N Engl J Med,2015

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modified spatial architecture of regulatory T cells after neoadjuvant chemotherapy in non-small cell lung cancer patients;International Immunopharmacology;2024-08

2. Unveiling the landscape of pathomics in personalized immunotherapy for lung cancer: a bibliometric analysis;Frontiers in Oncology;2024-07-08

3. RPS24 alternative splicing is a marker of cancer progression and epithelial-mesenchymal transition;Scientific Reports;2024-06-10

4. The Human Pathology Atlas for deciphering the prognostic features of human cancers;2024-06-10

5. Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer;Nature Communications;2024-05-07